Company

1

History

Since 2000

This is the historical footprint that Genomictree has been with you

2019

09

Establish US branch (Promis Diagnostics)

05

Launch EarlyTect® Colon Cancer Test in Korea

03

Join the KOSDAQ (228760)

2018

09

Construct Molecular Diagnostics Laboratory

08

Approval of EarlyTect® Colon Cancer

Investment attraction (Daily Partners)

2017

12

Land purchase contract of Daejeon Science Business Belt area (6000 square meter)

09

Investment attraction (KBIC & Solidus)

2016

07

Join the KONEX (228760)

2015

12

CE-IVD of EarlyTect® Colon Cancer

10

Investment attraction (Magna)

09

Select as K-Brain Power Company

02

Certify ISO13485

2014

09

Medical Device Award in Bio-IP Technology Golden Bell

07

Investment attraction (KBIC)

06

Certify KGMP (MFDS)

04

Approval of EarlyTect GI Syndecan2 Methylation Assay (MFDS)

04

Medical Device Manufacturing License (MFDS)

2013

11

Encouragement Prize at the 1st Korea IP Champion Competition

01

Certify Health New Technology (NET)

2009

07

Certify Inno-Biz grade A

2008

09

Factory registration (manufacturing IVD device)

08

Relocation of Head office (Tanipdong)

2007

05

National research grant on bladder cancer (MTIE Korea)

2005

12

Investment Attraction (KDB capital)

05

National research grant on lung cancer (MHW Korea)

2004

05

National research grant on colorectal cancer (MHW Korea)

2003

11

Certify ISO9001

2002

09

Develop methylation biomarker discovery technology

2001

09

Certify venture business

05

Construct microarray operating system

02

Certify company affiliated research institute

2000

10

Establish Genomictree